GREGORY JULIA P Insider Trading Activity

Average Profitability
17.49%
Insider Buys Quantity
1
Insider Buys Sum
$99,991.50
Insider Sells Quantity
9
Insider Sells Sum
$3.54M

Insider Activity of GREGORY JULIA P

According to the SEC Form 4 filings, GREGORY JULIA P, being in a position of

  1. director at Nurix Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 22583 shares for $528,528,
    over all time since 2026-10-14, has bought 0 shares, and sold 22583 shares for $528,528.

Biography of GREGORY JULIA P

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $528,5281100

Comparison of Insiders on Amount of Buys and Sells

2026-10-14SaleNurix Therapeutics, Inc.
NRIX
director
22,583
0.0215%
$23.40$528,528+8.83%
2022-10-25PurchaseBiohaven Pharmaceutical Holding Company Ltd.
BHVN
director
9,523
0.0021%
$10.50$99,992+17.49%
2021-12-20SaleBiohaven Pharmaceutical Holding Company Ltd.
BHVN
director
12,000
0.0322%
$125.00$1.5M-68.35%
2019-11-22SaleBiohaven Pharmaceutical Holding Company Ltd.
BHVN
director
12,000
0.0141%
$54.75$656,957
2019-02-21SaleBiohaven Pharmaceutical Holding Company Ltd.
BHVN
director
12,000
0.0112%
$43.56$522,720
2006-01-04SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
14,400
0.0222%
$3.80$54,720+6.04%
2005-12-30SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
7,600
0.012%
$3.70$28,120+10.68%
2004-12-28SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
6,000
0.0093%
$7.60$45,618-39.48%
2004-05-03SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
72,000
0.1118%
$7.13$513,527-7.66%
2004-01-02SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
16,000
0.0252%
$6.01$96,176+13.55%
2003-12-26SaleLexicon Pharmaceuticals, Inc.
LXRX
EVP, Corp Dev and CFO
20,000
0.0315%
$5.92$118,380+15.13%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.